RE:RE:RE:New Article by Orange Peel Investments, Premium SA Exactly. All the Bank analysts, researchers and pundits loved the stock a year ago and pumped it to the retailers giving targets of over $100 USD. But they were dead wrong. Now everyone hates it and is giving it a sell—some wth targets as low as $.50.
So what is the truth? We know it wasn’t worth $100 USD. But is it worth $2 USD?
Here we have a Company who’s timing was dead wrong. A roll-up that needed to be financed just when Clinton tweeted, Shrekli gouged, Valeant was exposed, Pharma was attacked, Brexit happened and the Pound fell. This Company’s timing couldn’t be worse. It was the PERFECT storm.
BUT, the reality is, you now have a Company with over 200 products in over 90 countries. And sales of close to ONE BILLION dollars. How many Pharma companies you know that has such a network with sales close to a BILLION and sells for $2 USD?
Of course the debt is a big risk. But if they can stabilize, the potential windfall is HUGE. That is what is called investing. If you can’t acceot the risk, go buy a GIC.